These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32192851)

  • 1. Severe olmesartan-induced sprue-like enteropathy with good corticosteroid treatment response.
    Alonso-Beato R; González-Pérez JA; Demelo-Rodríguez P
    Rev Gastroenterol Mex (Engl Ed); 2020; 85(2):220-222. PubMed ID: 32192851
    [No Abstract]   [Full Text] [Related]  

  • 2. Olmesartan-associated sprue-like enteropathy: An emerging cause of drug-induced chronic diarrhea.
    Solano-Iturri G; García-Jiménez N; Solano-Iturri JD; Blanco-Sampascual S
    Rev Gastroenterol Mex (Engl Ed); 2018; 83(1):71-72. PubMed ID: 28291561
    [No Abstract]   [Full Text] [Related]  

  • 3. Olmesartan: sprue-like enteropathy.
    Prescrire Int; 2014 Apr; 23(148):102. PubMed ID: 24860900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute renal failure secondary to diarrhea due to sprue like-enteropathy associated with olmesartan].
    Ulla-Rocha JL; Lopez-Piñeiro S; Puga-Gimenez M
    Gastroenterol Hepatol; 2015 Oct; 38(8):514-5. PubMed ID: 25534549
    [No Abstract]   [Full Text] [Related]  

  • 5. [Enteropathy by olmesartan].
    Téllez Villajos L; Crespo Pérez L; Cano Ruiz A; Moreira Vicente V
    Med Clin (Barc); 2015 Feb; 144(3):140-1. PubMed ID: 25194976
    [No Abstract]   [Full Text] [Related]  

  • 6. [Enteropathy associated with chronic use of olmesartan].
    Téllez A; Pellicé M; Llobell A; Milisenda JC
    Med Clin (Barc); 2015 Feb; 144(3):139-40. PubMed ID: 24930862
    [No Abstract]   [Full Text] [Related]  

  • 7. In brief: Olmesartan and sprue-like enteropathy.
    Med Lett Drugs Ther; 2018 Jan; 60(1539):24. PubMed ID: 29364200
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver injury related to olmesartan-associated sprue-like enteropathy.
    Kogachi S; Treyzon L; Waters K; Sundaram V
    Liver Int; 2019 Nov; 39(11):2204. PubMed ID: 31423708
    [No Abstract]   [Full Text] [Related]  

  • 9. [Olmesartan therapy and enteropathy: About two cases and review of the literature].
    Sadki A; Le Besnerais M; Héron F; Marie I
    Rev Med Interne; 2019 Feb; 40(2):112-116. PubMed ID: 30174111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy and therapeutics committees strategy to address olmesartan safety issues at a primary care level.
    Rovira-Illamola M; Pagès-Puigdemont N; Sotoca-Momblona JM; Mensa-Vendrell M; Barba-Ávila O; Casasayas-Guilera M
    Int J Clin Pharm; 2020 Apr; 42(2):737-743. PubMed ID: 32078107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olmesartan-associated sprue-like enteropathy: a systematic review with emphasis on histopathology.
    Burbure N; Lebwohl B; Arguelles-Grande C; Green PH; Bhagat G; Lagana S
    Hum Pathol; 2016 Apr; 50():127-34. PubMed ID: 26997446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sprue-like enteropathy in the elderly treated with olmesartan].
    Calvo Beguería E; Martinez Huguet C; Gonzalez García MP; Omiste SanVicente T
    Rev Esp Geriatr Gerontol; 2017; 52(4):223-224. PubMed ID: 28277303
    [No Abstract]   [Full Text] [Related]  

  • 13. Olmesartan-associated sprue-like enteropathy.
    Stanich PP; Yearsley M; Meyer MM
    J Clin Gastroenterol; 2013; 47(10):894-5. PubMed ID: 23751857
    [No Abstract]   [Full Text] [Related]  

  • 14. Olmesartan-induced enteropathy treated with budesonide.
    Kempenaers S; Bogaert J; De Maeyer M; Van Hauthem P; Ramael M; Schoeters P
    Acta Gastroenterol Belg; 2019; 82(2):319-321. PubMed ID: 31314195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case of Olmesartan-associated Sprue-like Enteropathy.
    Nagashima K; Katsurada T; Sakamoto N
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):A45-A46. PubMed ID: 29247793
    [No Abstract]   [Full Text] [Related]  

  • 16. Olmesartan: sprue-like enteropathy.
    Prescrire Int; 2016 May; 25(171):130-1. PubMed ID: 27280200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olmesartan worsening known thrombocytopenia. A rare side effect of antihypertensive drugs.
    Sanidas EA; Tzanis G; Papadopoulos D; Barbetseas J; Papademetriou V
    Hellenic J Cardiol; 2017; 58(1):96-97. PubMed ID: 28163153
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute kidney injury secondary to diarrhea caused by "sprue-like" enteropathy associated with olmesartan.
    Roca-Argente L; Diaz-Jaime FC; López-Romero LC; Manzur-Aguilar Y; Moll-Guillem JL; Del Val-Antoñana A; Hernandez-Jaras J
    Nefrologia; 2017; 37(5):548-550. PubMed ID: 28027786
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe intestinal malabsorption associated with olmesartan: a French nationwide observational cohort study.
    Basson M; Mezzarobba M; Weill A; Ricordeau P; Allemand H; Alla F; Carbonnel F
    Gut; 2016 Oct; 65(10):1664-9. PubMed ID: 26250345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olmesartan-Associated Enteropathy: A Review of Clinical and Histologic Findings.
    Choi EY; McKenna BJ
    Arch Pathol Lab Med; 2015 Oct; 139(10):1242-7. PubMed ID: 26414468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.